Stroke Adverse Outcome is Associated With Nosocomial Infections: PCTus- Guided Antibacterial Therapy in Severe Ischemic Stroke Patients (STRAWINSKI)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 230 participants.

Also called NCT01264549

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 230 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01264549
Other papers using this trial's data
  • Selection bias in clinical stroke trials depending on ability to consent BMC neurology, 2017-12-04 DOI, PubMed 29202730, PMC5716230 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany, Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01264549. Randomized; double masking; primary purpose treatment. Start 2010-12 (registry gives no type); primary completion 2014-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Stroke Adverse Outcome is Associated With Nosocomial Infections: PCTus- Guided Antibacterial Therapy in Severe Ischemic Stroke Patients (STRAWINSKI)
Acronym
STRAWINSKI
Intervention (Device)
Procalcitonin assay - B.R.A.H.M.S PCT ultrasensitive Kryptor
Lead sponsor
Charite University, Berlin, Germany (class: other)
Collaborator
Brahms AG (class: industry)
Collaborator
NeuroCure Clinical Research Center, Charite, Berlin (class: other)

Record details

Record id
cardio:ct-nct01264549
Content hash
2a6f167a7c2badfce57ccfbb2e2c15ef38d689a72fd3fffb66867c20836c107b